Cargando…

Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy

Atherosclerosis, the principle cause of cardiovascular disease (CVD) worldwide, is mainly characterized by the pathological accumulation of diseased vascular cells and apoptotic cellular debris. Atherogenesis is associated with the upregulation of CD47, a key antiphagocytic molecule that is known to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Liang, Zhou, Zhongyi, Hu, Cheng, Maitz, Manfred F., Yang, Li, Luo, Rifang, Wang, Yunbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791388/ https://www.ncbi.nlm.nih.gov/pubmed/35118420 http://dx.doi.org/10.34133/2022/9845459

Ejemplares similares

A thrombin-triggered self-regulating anticoagulant strategy combined with anti-inflammatory capacity for blood-contacting implants
por: Wang, Yanan, et al.
Publicado: (2022)

Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques
por: Zhou, Jia, et al.
Publicado: (2022)

Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques
por: Almer, Gunter, et al.
Publicado: (2011)

Characterization of Atherosclerotic Plaque Coating for Thrombosis Microfluidics Assays
por: Karel, M. F. A., et al.
Publicado: (2021)

Multifunctional mussel-inspired copolymerized epigallocatechin gallate (EGCG)/arginine coating: the potential as an ad-layer for vascular materials
por: Luo, Rifang, et al.
Publicado: (2016)

Identifying RBM47, HCK, CD53, TYROBP, and HAVCR2 as Hub Genes in Advanced Atherosclerotic Plaques by Network-Based Analysis and Validation
por: Liu, Chiyu, et al.
Publicado: (2021)

Platelet‐Mimicking Therapeutic System for Noninvasive Mitigation of the Progression of Atherosclerotic Plaques
por: Ma, Yi, et al.
Publicado: (2021)

Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques
por: Rutten, Bert, et al.
Publicado: (2014)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Electrospun silk fibroin/poly (L-lactide-ε-caplacton) graft with platelet-rich growth factor for inducing smooth muscle cell growth and infiltration
por: Yin, Anlin, et al.
Publicado: (2016)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
por: Su, Chen, et al.
Publicado: (2022)

Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
por: Jamasbi, Janina, et al.
Publicado: (2016)

Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity
por: Oggero, Silvia, et al.
Publicado: (2021)

Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation
por: Mauersberger, Carina, et al.
Publicado: (2022)

An extracellular matrix-mimetic coating with dual bionics for cardiovascular stents
por: Chen, Nuoya, et al.
Publicado: (2023)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

Elimination of Cancer Cells in Co-Culture: Role of Different Nanocarriers in Regulation of CD47 and Calreticulin-Induced Phagocytosis
por: Hassan, Eman M., et al.
Publicado: (2023)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy
por: Liu, Shengyang, et al.
Publicado: (2022)

Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
por: Jamasbi, Janina, et al.
Publicado: (2015)

Fibroblast growth factor‐2/platelet‐derived growth factor enhances atherosclerotic plaque stability
por: Mao, Yang, et al.
Publicado: (2019)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice
por: Theelen, Thomas L., et al.
Publicado: (2015)

Cell Membrane-Coated Halloysite Nanotubes for Target-Specific Nanocarrier for Cancer Phototherapy
por: Tan, Cuiying, et al.
Publicado: (2021)

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

The Elusive Origin of Atherosclerotic Plaque Calcification
por: Canet-Soulas, Emmanuelle, et al.
Publicado: (2021)

Clinical Molecular Imaging for Atherosclerotic Plaque
por: Kondakov, Anton, et al.
Publicado: (2021)

Cellular crosstalk in atherosclerotic plaque microenvironment
por: Mahdinia, Elmira, et al.
Publicado: (2023)

Residual risks and evolving atherosclerotic plaques
por: Noothi, Sunil K., et al.
Publicado: (2023)

Ag-Incorporated Polydopamine/Tannic Acid Coating on Titanium With Enhanced Cytocompatible and Antibacterial Properties
por: Zhang, Hao, et al.
Publicado: (2022)

Phage Display Identification of CD100 in Human Atherosclerotic Plaque Macrophages and Foam Cells
por: Luque, Maria Carolina Aquino, et al.
Publicado: (2013)

Microfluidics‐Enabled Nanovesicle Delivers CD47/PD‐L1 Antibodies to Enhance Antitumor Immunity and Reduce Immunotoxicity in Lung Adenocarcinoma
por: Su, Zhenwei, et al.
Publicado: (2023)

Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke
por: Wang, Cheng, et al.
Publicado: (2022)

Lysis of antibody-coated cells by platelets
Publicado: (1982)

Membrane-Mediated Cooperative Interactions of CD47 and SIRPα
por: Li, Long, et al.
Publicado: (2023)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis
por: Kojima, Yoko, et al.
Publicado: (2016)

Anti-CD47 antibody eliminates bone tumors in rats
por: Fang, Shiqiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b1ke3oqd8oh65qembcp919jkha